Rerandomization CRF in Technology-Based Stepped Care to Stem Transgender Adolescent (TechStep) Risk Transmission

Data from the Rerandomization CRF at the 3 month visit
Study Description
TechStep was a three-arm, technology-based randomized controlled trial (RCT), with a stepped care approach, among high-risk HIV-negative transgender feminine, transgender masculine, and gender non-conforming youth and young adults for reducing sexual risk behaviors and increasing pre-exposure prophylaxis (PrEP) uptake. Participants were randomized into one of three conditions for a 6-month intervention: Group 1: culturally relevant theory-based text messages (Text+Step); or, Group 2: culturally relevant mobile-enhanced website (WebApp+Step); or, Group 3: informational website control condition with no theoretically based text messages or WebApp. Out of the 284 participants enrolled, 30 were withdrawn due to not returning a baseline HIV test.

3个月随访时的再随机化病例报告表（CRF）数据
研究概况
TechStep 是一项采用阶梯式护理方案的三臂技术型随机对照试验（RCT），针对HIV阴性且属HIV感染高风险的跨性别女性、跨性别男性及性别非顺从青年与年轻成人开展，旨在降低其性风险行为发生率，提高暴露前预防（PrEP）的服用率。所有参与者被随机分配至3组接受为期6个月的干预：第1组：文化适配的理论导向短信干预（Text+Step）；第2组：文化适配的移动增强型网站干预（WebApp+Step）；第3组：仅提供信息的网站对照组，不包含基于理论的短信或WebApp干预。在招募的284名参与者中，有30人因未提交基线HIV检测结果而被退出研究。